WA
CVS icon

WBH Advisory’s CVS Health CVS Stock Holding History

WBH Advisory’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,715
Closed -$295K – 354
2025
Q4 		$295K Sell
3,715
-1,056
-22% -$83.3K 0.02% 293
2025
Q3 		$360K Buy
4,771
+79
+2% +$5.41K 0.03% 271
2025
Q2 		$324K Sell
4,692
-581
-11% -$38.1K 0.03% 281
2025
Q1 		$357K Sell
5,273
-1,488
-22% -$89K 0.03% 249
2024
Q4 		$303K Sell
6,761
-965
-12% -$54.1K 0.03% 264
2024
Q3 		$486K Sell
7,726
-810
-9% -$47.3K 0.05% 218
2024
Q2 		$504K Sell
8,536
-1,169
-12% -$73.1K 0.05% 209
2024
Q1 		$774K Sell
9,705
-611
-6% -$46.7K 0.08% 174
2023
Q4 		$815K Sell
10,316
-138
-1% -$9.82K 0.09% 166
2023
Q3 		$730K Sell
10,454
-250
-2% -$17.7K 0.09% 166
2023
Q2 		$740K Sell
10,704
-90
-0.8% -$6.4K 0.09% 167
2023
Q1 		$802K Buy
+10,794
New +$905K 0.1% 163
2022
Q3 		$1.02M Sell
10,735
-48
-0.4% -$4.75K 0.15% 140
2022
Q2 		$1.02M Buy
10,783
+2
+0% +$195 0.14% 137
2022
Q1 		$1.09M Sell
10,781
-348
-3% -$36.6K 0.13% 138
2021
Q4 		$1.15M Buy
11,129
+2
+0% +$185 0.13% 140
2021
Q3 		$944K Sell
11,127
-47
-0.4% -$3.94K 0.13% 147
2021
Q2 		$926K Buy
11,174
+2
+0% +$164 0.14% 131
2021
Q1 		$840K Sell
11,172
-597
-5% -$43.5K 0.14% 129
2020
Q4 		$886K Sell
11,769
-397
-3% -$25.8K 0.15% 117
2020
Q3 		$711K Sell
12,166
-315
-3% -$19.6K 0.14% 123
2020
Q2 		$810K Sell
12,481
-256
-2% -$16.1K 0.2% 106
2020
Q1 		$755 Sell
12,737
-509
-4% -$34K 0.18% 103
2019
Q4 		$984K Sell
13,246
-2,014
-13% -$141K 0.2% 110
2019
Q3 		$962K Sell
15,260
-228
-1% -$13.5K 0.22% 104
2019
Q2 		$843K Sell
15,488
-1,999
-11% -$108K 0.2% 110
2019
Q1 		$943K Sell
17,487
-2,092
-11% -$129K 0.22% 103
2018
Q4 		$1.28K Buy
19,579
+1,083
+6% +$80.8K 0.31% 77
2018
Q3 		$1.46M Sell
18,496
-773
-4% -$55.3K 0.35% 68
2018
Q2 		$1.24M Sell
19,269
-510
-3% -$33.6K 0.32% 75
2018
Q1 		$1.23M Buy
19,779
+2
+0% +$143 0.33% 75
2017
Q4 		$1.43M Sell
19,777
-1,420
-7% -$103K 0.38% 64
2017
Q3 		$1.72M Sell
21,197
-630
-3% -$49.8K 0.48% 49
2017
Q2 		$1.76M Sell
21,827
-2,451
-10% -$194K 0.49% 47
2017
Q1 		$1.91M Buy
24,278
+2,158
+10% +$172K 0.57% 42
2016
Q4 		$1.75M Sell
22,120
-397
-2% -$32.1K 0.58% 44
2016
Q3 		$2M Buy
22,517
+5
+0% +$472 0.69% 36
2016
Q2 		$2.15M Sell
22,512
-734
-3% -$73.2K 0.84% 28
2016
Q1 		$2.41M Buy
23,246
+1,610
+7% +$157K 0.81% 21
2015
Q4 		$2.12K Sell
21,636
-480
-2% -$47K 0.74% 28
2015
Q3 		$2.13M Buy
22,116
+153
+0.7% +$16.1K 0.89% 24
2015
Q2 		$2.3M Sell
21,963
-220
-1% -$22.5K 0.91% 21
2015
Q1 		$2.29K Sell
22,183
-2,445
-10% -$247K 0.64% 25
2014
Q4 		$2.37M Buy
24,628
+235
+1% +$20.7K 0.89% 24
2014
Q3 		$1.94M Sell
24,393
-237
-1% -$18.7K 0.68% 28
2014
Q2 		$1.86M Sell
24,630
-24
-0.1% -$1.81K 0.7% 31
2014
Q1 		$1.84M Sell
24,654
-850
-3% -$60K 0.73% 29
2013
Q4 		$1.82M Buy
25,504
+155
+0.6% +$9.96K 0.74% 27
2013
Q3 		$1.44M Buy
25,349
+416
+2% +$24.8K 0.64% 36
2013
Q2 		$1.43M Buy
+24,933
New +$1.44M 0.66% 37

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WBH Advisory's CVS Position: Q1 2026 in Review

WBH Advisory sold out of CVS Health (CVS) in Q1 2026, closing a stake of 3,715 shares — an estimated $295K sold.

WBH Advisory first reported a position in CVS in Q2 2013 and held it in 50 quarters. The position peaked at $2.41M in Q1 2016. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • WBH Advisory reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • WBH Advisory sold 3,715 CVS Health shares in Q1 2026, an estimated $295K.
  • WBH Advisory first reported a position in CVS Health in Q2 2013 and held it in 50 quarters.
  • WBH Advisory's CVS Health position peaked at $2.41M in Q1 2016.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on WBH Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.